Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28376 - 28400 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	CYBA	1535	downregulated	Cytarabine results in decreased expression of CYBA mRNA	16q24.2	A21886
Cytarabine	Approved Investigational	CYP27A1	1593	downregulated	Cytarabine results in decreased expression of CYP27A1 mRNA	2q35	A21886
Cytarabine	Approved Investigational	CYP4X1	260293	downregulated	Cytarabine results in decreased expression of CYP4X1 mRNA	1p33	A21886
Cytarabine	Approved Investigational	CYTH1	9267	upregulated	Cytarabine results in increased expression of CYTH1 mRNA	17q25.3	A20985
Cytarabine	Approved Investigational	DAB2	1601	downregulated	Cytarabine results in decreased expression of DAB2 mRNA	5p13.1	A21886
Cytarabine	Approved Investigational	DALRD3	55152	downregulated	Cytarabine results in decreased expression of DALRD3 mRNA	3p21.31	A20985
Cytarabine	Approved Investigational	DBN1	1627	downregulated	Cytarabine results in decreased expression of DBN1 mRNA	5q35.3	A20985
Cytarabine	Approved Investigational	DCN	1634	downregulated	Cytarabine results in decreased expression of DCN mRNA	12q21.33	A21886
Cytarabine	Approved Investigational	DDR2	4921	downregulated	Cytarabine results in decreased expression of DDR2 mRNA	1q23.3	A21886
Cytarabine	Approved Investigational	DENND1A	57706	upregulated	Cytarabine results in increased expression of DENND1A mRNA	9q33.3	A20985
Cytarabine	Approved Investigational	DHCR24	1718	downregulated	Cytarabine results in decreased expression of DHCR24 mRNA	1p32.3	A21886
Cytarabine	Approved Investigational	DHFR	1719	upregulated	Cytarabine results in increased expression of DHFR mRNA	5q14.1	A20985
Cytarabine	Approved Investigational	DISP3	57540	upregulated	Cytarabine results in increased expression of DISP3 mRNA	1p36.22	A21886
Cytarabine	Approved Investigational	DNAH2	146754	downregulated	Cytarabine results in decreased expression of DNAH2 mRNA	17p13.1	A21886
Cytarabine	Approved Investigational	DOK4	55715	downregulated	Cytarabine results in decreased expression of DOK4 mRNA	16q21	A21886
Cytarabine	Approved Investigational	DSC2	1824	downregulated	Cytarabine results in decreased expression of DSC2 mRNA	18q12.1	A21886
Cytarabine	Approved Investigational	DSC3	1825	downregulated	Cytarabine results in decreased expression of DSC3 mRNA	18q12.1	A21886
Cytarabine	Approved Investigational	DUSP4	1846	downregulated	Cytarabine results in decreased expression of DUSP4 mRNA	8p12	A20985
Cytarabine	Approved Investigational	EEF2	1938	downregulated	Cytarabine results in decreased expression of EEF2 mRNA	19p13.3	A21886
Cytarabine	Approved Investigational	EFEMP2	30008	downregulated	Cytarabine results in decreased expression of EFEMP2 mRNA	11q13.1	A21886
Cytarabine	Approved Investigational	EFHD1	80303	downregulated	Cytarabine results in decreased expression of EFHD1 mRNA	2q37.1	A21886
Cytarabine	Approved Investigational	EFNA1	1942	downregulated	Cytarabine results in decreased expression of EFNA1 mRNA	1q22	A21886
Cytarabine	Approved Investigational	EGFEM1P	93556	upregulated	Cytarabine results in increased expression of EGFEM1P mRNA	3q26.2	A21886
Cytarabine	Approved Investigational	EGFL6	25975	downregulated	Cytarabine results in decreased expression of EGFL6 mRNA	Xp22.2	A21886
Cytarabine	Approved Investigational	EGFLAM	133584	downregulated	Cytarabine results in decreased expression of EGFLAM mRNA	5p13.2-p13.1	A21886

Displaying entries 28376 - 28400 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability